A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...
Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech’s New York Reference Laboratory DUBLIN and NEW YORK, ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Medindia on MSN
Novel ctDNA blood test to track and treat prostate cancer
India, March 23 -- Advances in cancer research are improving how doctors diagnose and monitor diseases. One emerging tool is ...
Rishi Sunak has urged men to be checked for prostate cancer as part of a new screening drive. The former prime minister has ...
A prostate cancer screening trial will make recruiting black men a priority because they face double the risk of getting the ...
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...
Prostate cancer kills more than 12,000 men a year in the UK, slightly more than the number of women who die from breast ...
Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech's New York Reference Laboratory DUBLIN and NEW YORK, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results